 | • レポートコード：GIR-22F20762 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医療機器 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Molecular Diagnostics Systems Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の分子診断用装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 分子診断用装置市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・PCR、ハイブリダイゼーション、DNAシーケンシング アプリケーション別セグメントは次のように区分されます。 ・病院、研究所 世界の分子診断用装置市場の主要な市場プレーヤーは以下のとおりです。 ・Abbott Laboratories、Qiagen N.V.、Roche Diagnostics、Hologic, Inc.、Grifols、Siemens Healthcare、Becton, Dickinson and Company、Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)、Biomérieux Sa、Cepheid Inc 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、分子診断用装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な分子診断用装置メーカーの企業概要、2019年～2022年までの分子診断用装置の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な分子診断用装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別分子診断用装置の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの分子診断用装置のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での分子診断用装置市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および分子診断用装置の産業チェーンを掲載しています。 ・第13、14、15章では、分子診断用装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 分子診断用装置の概要 - タイプ別分析（2017年vs2021年vs2028年）：PCR、ハイブリダイゼーション、DNAシーケンシング - アプリケーション別分析（2017年vs2021年vs2028年）：病院、研究所 - 世界の分子診断用装置市場規模・予測 - 世界の分子診断用装置生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Abbott Laboratories、Qiagen N.V.、Roche Diagnostics、Hologic, Inc.、Grifols、Siemens Healthcare、Becton, Dickinson and Company、Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)、Biomérieux Sa、Cepheid Inc ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：PCR、ハイブリダイゼーション、DNAシーケンシング ・アプリケーション別分析2017年-2028年：病院、研究所 ・分子診断用装置の北米市場分析 - 分子診断用装置の北米市場：タイプ別市場規模2017年-2028年 - 分子診断用装置の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・分子診断用装置のヨーロッパ市場分析 - ：分子診断用装置のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：分子診断用装置のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・分子診断用装置のアジア太平洋市場分析 - 分子診断用装置のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 分子診断用装置のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・分子診断用装置の南米市場分析 - 分子診断用装置の南米市場：タイプ別市場規模2017年-2028年 - 分子診断用装置の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・分子診断用装置の中東・アフリカ市場分析 - 分子診断用装置の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 分子診断用装置の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Molecular Diagnostics Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Molecular Diagnostics Systems market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Molecular Diagnostics Systems global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While PCR segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Molecular Diagnostics Systems include Abbott Laboratories, Qiagen N.V., Roche Diagnostics, Hologic, Inc., and Grifols, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Molecular Diagnostics Systems market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
PCR
Hybridization
DNA Sequencing
Market segment by Application can be divided into
Hospitals
Laboratories
The key market players for global Molecular Diagnostics Systems market are listed below:
Abbott Laboratories
Qiagen N.V.
Roche Diagnostics
Hologic, Inc.
Grifols
Siemens Healthcare
Becton, Dickinson and Company
Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
Biomérieux Sa
Cepheid Inc
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Molecular Diagnostics Systems product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Molecular Diagnostics Systems, with price, sales, revenue and global market share of Molecular Diagnostics Systems from 2019 to 2022.
Chapter 3, the Molecular Diagnostics Systems competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Molecular Diagnostics Systems breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Molecular Diagnostics Systems market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Diagnostics Systems.
Chapter 13, 14, and 15, to describe Molecular Diagnostics Systems sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Molecular Diagnostics Systems Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Molecular Diagnostics Systems Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 PCR
1.2.3 Hybridization
1.2.4 DNA Sequencing
1.3 Market Analysis by Application
1.3.1 Overview: Global Molecular Diagnostics Systems Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Laboratories
1.4 Global Molecular Diagnostics Systems Market Size & Forecast
1.4.1 Global Molecular Diagnostics Systems Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Molecular Diagnostics Systems Sales in Volume (2017-2028)
1.4.3 Global Molecular Diagnostics Systems Price (2017-2028)
1.5 Global Molecular Diagnostics Systems Production Capacity Analysis
1.5.1 Global Molecular Diagnostics Systems Total Production Capacity (2017-2028)
1.5.2 Global Molecular Diagnostics Systems Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Molecular Diagnostics Systems Market Drivers
1.6.2 Molecular Diagnostics Systems Market Restraints
1.6.3 Molecular Diagnostics Systems Trends Analysis
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Molecular Diagnostics Systems Product and Services
2.1.4 Abbott Laboratories Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Qiagen N.V.
2.2.1 Qiagen N.V. Details
2.2.2 Qiagen N.V. Major Business
2.2.3 Qiagen N.V. Molecular Diagnostics Systems Product and Services
2.2.4 Qiagen N.V. Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche Diagnostics
2.3.1 Roche Diagnostics Details
2.3.2 Roche Diagnostics Major Business
2.3.3 Roche Diagnostics Molecular Diagnostics Systems Product and Services
2.3.4 Roche Diagnostics Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Hologic, Inc.
2.4.1 Hologic, Inc. Details
2.4.2 Hologic, Inc. Major Business
2.4.3 Hologic, Inc. Molecular Diagnostics Systems Product and Services
2.4.4 Hologic, Inc. Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Grifols
2.5.1 Grifols Details
2.5.2 Grifols Major Business
2.5.3 Grifols Molecular Diagnostics Systems Product and Services
2.5.4 Grifols Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Siemens Healthcare
2.6.1 Siemens Healthcare Details
2.6.2 Siemens Healthcare Major Business
2.6.3 Siemens Healthcare Molecular Diagnostics Systems Product and Services
2.6.4 Siemens Healthcare Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Becton, Dickinson and Company
2.7.1 Becton, Dickinson and Company Details
2.7.2 Becton, Dickinson and Company Major Business
2.7.3 Becton, Dickinson and Company Molecular Diagnostics Systems Product and Services
2.7.4 Becton, Dickinson and Company Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation)
2.8.1 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Details
2.8.2 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Major Business
2.8.3 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Product and Services
2.8.4 Beckman Coulter Inc. (A Wholly Owned Subsidiary of Danaher Corporation) Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Biomérieux Sa
2.9.1 Biomérieux Sa Details
2.9.2 Biomérieux Sa Major Business
2.9.3 Biomérieux Sa Molecular Diagnostics Systems Product and Services
2.9.4 Biomérieux Sa Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Cepheid Inc
2.10.1 Cepheid Inc Details
2.10.2 Cepheid Inc Major Business
2.10.3 Cepheid Inc Molecular Diagnostics Systems Product and Services
2.10.4 Cepheid Inc Molecular Diagnostics Systems Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Molecular Diagnostics Systems Breakdown Data by Manufacturer
3.1 Global Molecular Diagnostics Systems Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Molecular Diagnostics Systems Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Molecular Diagnostics Systems
3.4 Market Concentration Rate
3.4.1 Top 3 Molecular Diagnostics Systems Manufacturer Market Share in 2021
3.4.2 Top 6 Molecular Diagnostics Systems Manufacturer Market Share in 2021
3.5 Global Molecular Diagnostics Systems Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Molecular Diagnostics Systems Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Molecular Diagnostics Systems Market Size by Region
4.1.1 Global Molecular Diagnostics Systems Sales in Volume by Region (2017-2028)
4.1.2 Global Molecular Diagnostics Systems Revenue by Region (2017-2028)
4.2 North America Molecular Diagnostics Systems Revenue (2017-2028)
4.3 Europe Molecular Diagnostics Systems Revenue (2017-2028)
4.4 Asia-Pacific Molecular Diagnostics Systems Revenue (2017-2028)
4.5 South America Molecular Diagnostics Systems Revenue (2017-2028)
4.6 Middle East and Africa Molecular Diagnostics Systems Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Molecular Diagnostics Systems Sales in Volume by Type (2017-2028)
5.2 Global Molecular Diagnostics Systems Revenue by Type (2017-2028)
5.3 Global Molecular Diagnostics Systems Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Molecular Diagnostics Systems Sales in Volume by Application (2017-2028)
6.2 Global Molecular Diagnostics Systems Revenue by Application (2017-2028)
6.3 Global Molecular Diagnostics Systems Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Molecular Diagnostics Systems Sales by Type (2017-2028)
7.2 North America Molecular Diagnostics Systems Sales by Application (2017-2028)
7.3 North America Molecular Diagnostics Systems Market Size by Country
7.3.1 North America Molecular Diagnostics Systems Sales in Volume by Country (2017-2028)
7.3.2 North America Molecular Diagnostics Systems Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Molecular Diagnostics Systems Sales by Type (2017-2028)
8.2 Europe Molecular Diagnostics Systems Sales by Application (2017-2028)
8.3 Europe Molecular Diagnostics Systems Market Size by Country
8.3.1 Europe Molecular Diagnostics Systems Sales in Volume by Country (2017-2028)
8.3.2 Europe Molecular Diagnostics Systems Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Molecular Diagnostics Systems Sales by Type (2017-2028)
9.2 Asia-Pacific Molecular Diagnostics Systems Sales by Application (2017-2028)
9.3 Asia-Pacific Molecular Diagnostics Systems Market Size by Region
9.3.1 Asia-Pacific Molecular Diagnostics Systems Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Molecular Diagnostics Systems Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Molecular Diagnostics Systems Sales by Type (2017-2028)
10.2 South America Molecular Diagnostics Systems Sales by Application (2017-2028)
10.3 South America Molecular Diagnostics Systems Market Size by Country
10.3.1 South America Molecular Diagnostics Systems Sales in Volume by Country (2017-2028)
10.3.2 South America Molecular Diagnostics Systems Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Molecular Diagnostics Systems Sales by Type (2017-2028)
11.2 Middle East & Africa Molecular Diagnostics Systems Sales by Application (2017-2028)
11.3 Middle East & Africa Molecular Diagnostics Systems Market Size by Country
11.3.1 Middle East & Africa Molecular Diagnostics Systems Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Molecular Diagnostics Systems Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Molecular Diagnostics Systems and Key Manufacturers
12.2 Manufacturing Costs Percentage of Molecular Diagnostics Systems
12.3 Molecular Diagnostics Systems Production Process
12.4 Molecular Diagnostics Systems Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Molecular Diagnostics Systems Typical Distributors
13.3 Molecular Diagnostics Systems Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer